LYKON

• 12/09/2022
• Series A
• $10,300,000

Empower people to live a healthy life.



This is not only the vision of our founder Tobias Teuber, but of the entire team.

We are a digital health company that was founded in 2015 and will change the healthcare system for the longterm. Our vision is to empower people to take their health into their own hands. We currently offer a wide range of DNA and blood tests. A few drops of blood or saliva are enough for us to provide customers with tailored nutrition and action recommendations to help them achieve their health goals. With our product, we are active in innovative and exciting fields, such as personalized nutrition and personalized medicine

How does it work?

You order these tests online, perform them easily at home and send them back to us by post. After our certified partner laboratories have successfully analysed the blood and DNA samples, you will receive the test results in your private Lykon profile presented in a clear and easy to understand way, and at the same time you will receive recommendations on how to improve your blood values if necessary.

Lykon does not replace medical advice, however, we enable you to control your health - without long waiting hours at the doctor's office.


Curious?


Learn more at www.lykon.de

---

---